| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_74de6abc4192d44119aff0f04da61957
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7050021963f78464bfb373824e2b68f8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2a85b04cc34ea458d115e164603d519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dfae81468523c4a7e635145a1bfe2359
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8c42b9f250fb7821b55df4a68a7222a4 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-146 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7061
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-10 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70 |
| filingDate |
2000-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fdbf138eb223974adb26d43b6d2accce
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4bf62bced8f69e05b43d8111e14658e8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ee86d3dedbce190ef7e1c71aa00ed4a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f0cc055448f7294ae8e6f0579efd6217 |
| publicationDate |
2000-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-0069421-A2 |
| titleOfInvention |
Transdermal therapeutic system (tts) containing tolterodine |
| abstract |
The invention relates to a transdermal therapeutic system (TTS) for transcutaneously administering tolterodine over a period of several days and to a method for producing the same. The TTS contains a self-adhesive layer-shaped matrix material which contains a (meth)acrylate copolymer comprising ammonium groups. The TTS also contains at least one softener and up to 25 wt. % of tolterodine. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10238612-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10179096-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0103678-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006081497-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9687428-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10869947-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006081497-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0103678-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9610253-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10835454-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2799066-B1 |
| priorityDate |
1999-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |